Please click here for prescribing information for Trulicity® (dulaglutide), Humalog® (insulin lispro) (UK and ROI), Abasaglar® (insulin glargine) and Lyumjev® (insulin lispro) (Lyumjev is not available in the ROI).
For more information about Lilly products please visit www.lillydiabetes.co.uk (UK only; this link is not available in the ROI)
Adverse events and product complaints should be reported. Reporting forms and further information can be found at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store (UK) or www.hpra.ie (ROI). Adverse events and product complaints should also be reported to Lilly: please call Lilly on +44 (0) 1256 315000 (UK) or +353 (0)1 664 0446 (ROI).
These promotional virtual conferences have been developed, organised and funded by Lilly in conjunction with the
Abracadabra Programme Planning Committee.
Lilly is a registered trademark of Eli Lilly and Company © 2020 Eli Lilly and Company. All rights reserved
Abracadabra Programme Planning Committee.
Lilly is a registered trademark of Eli Lilly and Company © 2020 Eli Lilly and Company. All rights reserved
PP-LD-GB-0793 July 2020
